16. The effectiveness of mild ovarian stimulation and vitrified oocyte accumulation in diminished ovarian reserve patients
Main Article Content
Abstract
This is a retrospective study conducted to evaluate the effectiveness of the combination of mild ovarian stimulation and oocyte accumulation in patients with diminished ovarian reserve. Results: the number of total metaphase II (M-II) oocytes/patient was 7.85 ± 3.52, the number of day 2 embryos was 5.31 ± 2.42. The survival rate of vitrified oocytes was 91.22%. There was no statistically significant difference in fertilization rate, embryo formation rate, the number of day 2 embryos and quality of day 2 embryos in the group using frozen oocytes and fresh oocytes for intracytoplasmic sperm injection. The pregnancy rate (PR), implantation rate (IR), and clinical pregnancy rate (CPR) were 50%, 28.89%, 38.46%, respectively. Conclusion: the combination of mild ovarian stimulation and initial oocyte retrieval has been shown to be effective in patients with diminished ovarian reserve.
Article Details
Keywords
mild ovarian stimulation, diminished ovarian reserve, oocyte accumulation, vitrified oocyte
References
2. Strauss JF, Williams CJ. Chapter 8 - Ovarian Life Cycle. In: Strauss JF, Barbieri RL, eds. Yen and Jaffe’s Reproductive Endocrinology (Eighth Edition). Elsevier; 2019:167-205.e9. doi:10.1016/B978-0-323-479 12-7.00008-1
3. Jirge PR. Poor ovarian reserve. J Hum Reprod Sci. 2016;9(2):63-69. doi:10.4103/0974-1208.183514
4. Wang P, Zhao C, Xu W, et al. The association between the number of oocytes retrieved and cumulative live birth rate in different female age strata. Sci Rep. 2023;13(1):14516. doi:10.1038/s41598-023-41842-7
5. Lee KS, Lin MH, Hwu YM, et al. The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study. Journal of Ovarian Research. 2023;16(1):49. doi:10.1186/s13048-023-01128-y
6. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: A guideline. Fertil Steril. 2013;99(1):37-43. doi:10.1016/j.fertnstert.2012.09.028
7. Youssef MAF, van Wely M, Mochtar M, et al. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis. Fertility and Sterility. 2018;109(2):289-301. doi:10.1016/j.fertnstert.2017.10.033
8. Humaidan P, Alviggi C, Fischer R, et al. The novel POSEIDON stratification of “Low prognosis patients in Assisted Reproductive Technology” and its proposed marker of successful outcome. F1000Res. 2016;5:2911. doi:10.12688/f1000research.10382.1
9. Kuwayama M, Vajta G, Kato O, et al. Highly efficient vitrification method for cryopreservation of human oocytes. Reproductive BioMedicine Online. 2005;11(3):300-308. doi:10.1016/S1472-6483(10)60837-1
10. Shin J, Kwon H, Choi DH, et al. Accumulated Vitrified Embryos Could Be a Method for Increasing Pregnancy Rates in Patients with Poor Ovarian Response. Journal of Clinical Medicine. 2022;11(17):4940. doi:10.3390/jcm11174940
11. Trịnh Thị Ngọc Yến, Dương Tiến Tùng, Hồ Nguyệt Minh, và cs. Chất lượng noãn, phôi và kết quả có thai của phác đồ kích thích buồng trứng nhẹ so với phác đồ kích thích buồng trứng liều cao ở bệnh nhân giảm dự trữ buồng trứng. Tạp chí Nghiên cứu Y học. 2022;159(11):132-139.
12. Cobo A, Garrido N, Crespo J, et al. Accumulation of oocytes: A new strategy for managing low-responder patients. Reprod Biomed Online. 2012;24(4):424-432. doi:10.1016/j.rbmo.2011.12.012
13. Khả LTH, Cầm TT, Toàn PD. Kết quả đông lạnh noãn ở bệnh nhân điều trị thụ tinh trong ống nghiệm. Tạp chí Phụ sản. 2020;18(1):45-48. doi:10.46755/vjog.2020.1.778
14. Walker Z, Lanes A, Ginsburg E. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation. Reprod Biol Endocrinol. 2022;20:10. doi:10.1186/s12958-021-00884-0